US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE512835C2
(sv)
*
|
1996-01-08 |
2000-05-22 |
Astrazeneca Ab |
Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
US6096340A
(en)
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
FR2771291B1
(fr)
*
|
1997-11-21 |
2000-02-25 |
Ethypharm Lab Prod Ethiques |
Spheroides, procede de preparation et compositions pharmaceutiques
|
EP1121103B1
(en)
|
1998-05-18 |
2006-12-20 |
Takeda Pharmaceutical Company Limited |
Orally disintegrable tablets comprising a benzimidazole
|
ES2347968T3
(es)
*
|
1998-07-28 |
2010-11-26 |
Takeda Pharmaceutical Company Limited |
Preparacion solida que se disgrega rapidamente.
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
US6733778B1
(en)
*
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9803772D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
SE0000774D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
EP1284729A4
(en)
*
|
2000-04-13 |
2007-12-19 |
Mayo Foundation |
REDUCTION AGENTS OF A (BETA) 42
|
US6761895B2
(en)
*
|
2000-04-17 |
2004-07-13 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug delivery system for averting pharmacokinetic drug interaction and method thereof
|
US20050118138A1
(en)
*
|
2000-07-19 |
2005-06-02 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
US7431920B2
(en)
*
|
2000-07-19 |
2008-10-07 |
Pepgen Corporation |
Method of treating IL-10 deficiency
|
US20050226845A1
(en)
*
|
2004-03-10 |
2005-10-13 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
US20050118137A1
(en)
*
|
2000-07-19 |
2005-06-02 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
US20040247565A1
(en)
*
|
2000-07-19 |
2004-12-09 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
US20050084478A1
(en)
*
|
2000-10-17 |
2005-04-21 |
Chih-Ping Liu |
Combination therapy using interferon-tau
|
US20050201981A1
(en)
*
|
2004-03-10 |
2005-09-15 |
Chih-Ping Liu |
Method of optimizing treatment with interferon-tau
|
US7737147B2
(en)
*
|
2000-07-27 |
2010-06-15 |
Thomas Nadackal Thomas |
Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US7029701B2
(en)
*
|
2000-09-11 |
2006-04-18 |
Andrx Pharmaceuticals, Llc |
Composition for the treatment and prevention of ischemic events
|
US20020192299A1
(en)
*
|
2000-12-28 |
2002-12-19 |
Rajneesh Taneja |
Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
|
CN1529587B
(zh)
*
|
2001-05-30 |
2010-05-12 |
欧洲凯尔特公司 |
含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
DK1411900T4
(da)
*
|
2001-06-01 |
2014-01-27 |
Pozen Inc |
Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs
|
KR100425226B1
(ko)
*
|
2001-07-03 |
2004-03-30 |
주식회사 팜트리 |
아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
|
SE0102993D0
(sv)
*
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
CA2461354C
(en)
|
2001-09-28 |
2010-04-27 |
Mcneil-Ppc, Inc. |
Fondant-based pharmaceutical composition
|
GB2380937A
(en)
*
|
2001-10-18 |
2003-04-23 |
David Ian Slovick |
Method of dispensing a plurality of medical substances into capsules
|
FR2831820B1
(fr)
*
|
2001-11-05 |
2004-08-20 |
Ethypharm Sa |
Comprime orodispersible presentant une grande homogeneite et son procede de preparation
|
ES2198195B1
(es)
*
|
2001-12-18 |
2004-10-01 |
Laboratorios Del Dr. Esteve, S.A. |
Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.
|
US20040082618A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Liquid dosage forms of acid labile drugs
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
CA2493156A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Nitromed, Inc. |
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
WO2004012659A2
(en)
|
2002-08-01 |
2004-02-12 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
DE10244504A1
(de)
*
|
2002-09-25 |
2004-04-08 |
Capsulution Nanoscience Ag |
Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
FR2845917B1
(fr)
*
|
2002-10-21 |
2006-07-07 |
Negma Gild |
Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
|
US20060029668A1
(en)
*
|
2002-10-24 |
2006-02-09 |
Ron Eyal S |
Sustained release L-arginine formulations and methods of manufacture and use
|
US20080145424A1
(en)
*
|
2002-10-24 |
2008-06-19 |
Enos Phramaceuticals, Inc. |
Sustained release L-arginine formulations and methods of manufacture and use
|
CA2503284A1
(en)
*
|
2002-10-24 |
2004-05-06 |
Enos Pharmaceuticals, Inc. |
Sustained release l-arginine formulations and methods of manufacture and use
|
US20050288373A1
(en)
*
|
2002-10-24 |
2005-12-29 |
Ron Eyal S |
Methods of treating various conditions by administration of sustained release L-arginine
|
US20070243251A1
(en)
*
|
2002-12-20 |
2007-10-18 |
Rajneesh Taneja |
Dosage Forms Containing A PPI, NSAID, and Buffer
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
WO2004056336A2
(en)
*
|
2002-12-20 |
2004-07-08 |
Ranbaxy Laboratories Limited |
Controlled release, multiple unit drug delivery systems
|
EP1575566B1
(en)
*
|
2002-12-26 |
2012-02-22 |
Pozen, Inc. |
Multilayer dosage forms containing naproxen and triptans
|
WO2004062552A2
(en)
*
|
2003-01-09 |
2004-07-29 |
Galephar M/F |
Pharmaceutical composition containing a nsaid and a benzimidazole derivative
|
WO2004064815A1
(en)
*
|
2003-01-21 |
2004-08-05 |
Smartrix Technologies Inc. |
Oral dosage formulation
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
|
EP1462098B1
(en)
*
|
2003-03-03 |
2007-07-04 |
SPRL Franpharma |
Stabilised pharmaceutical composition comprising a non-steroidal anti-inflammatory agent and a prostaglandin
|
PE20050150A1
(es)
*
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
*
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
CN101524336B
(zh)
*
|
2003-05-08 |
2013-12-18 |
塔科达有限责任公司 |
含有泮托拉唑作为活性成分的剂型
|
EP1651195A4
(en)
*
|
2003-07-11 |
2007-10-03 |
Myriad Genetics Inc |
PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AR045068A1
(es)
*
|
2003-07-23 |
2005-10-12 |
Univ Missouri |
Formulacion de liberacion inmediata de composiciones farmaceuticas
|
AU2004279298B2
(en)
*
|
2003-09-29 |
2009-01-29 |
Palmetto Pharmaceuticals, Llc |
Sustained release L-arginine formulations and methods of manufacture and use
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
WO2005032554A1
(en)
|
2003-10-03 |
2005-04-14 |
Astron Research Pvt. Ltd |
A novel transmucosal delivery system
|
EP1677770A2
(en)
*
|
2003-10-31 |
2006-07-12 |
Dexcel Ltd. |
Stable lansoprazole formulation
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
WO2005074930A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Altana Pharma Ag |
Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
|
US20050249806A1
(en)
*
|
2004-02-10 |
2005-11-10 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
|
US20080025948A1
(en)
*
|
2004-03-10 |
2008-01-31 |
Chih-Ping Liu |
Methods of Treatment Using Interferon-Tau
|
US20060078942A1
(en)
*
|
2004-03-10 |
2006-04-13 |
Pepgen Corporation |
Method of treatment using interferon-tau
|
TW200533391A
(en)
*
|
2004-03-25 |
2005-10-16 |
Sun Pharmaceutical Ind Ltd |
Gastric retention drug delivery system
|
US20070293538A1
(en)
*
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
AU2005241023A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AU2005264864B2
(en)
|
2004-06-16 |
2011-08-11 |
Takeda Pharmaceutical Company Limited |
Multiple PPI dosage form
|
US20050281876A1
(en)
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
EA200971133A1
(ru)
*
|
2004-06-29 |
2010-10-29 |
Никомед Данмарк Апс |
Производство фармацевтических композиций с быстрым высвобождением на основе водонерастворимых лекарственных средств и фармацевтические композиции, получаемые способом по изобретению
|
CA2618985A1
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
US20080096927A1
(en)
*
|
2004-08-24 |
2008-04-24 |
Simon Thomas J |
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
|
US20060134210A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Astrazeneca Ab |
Solid dosage form comprising proton pump inhibitor and suspension made thereof
|
AU2006208293A1
(en)
*
|
2005-01-24 |
2006-08-03 |
Palmetto Pharmaceuticals, Llc |
Methods of treating various conditions by administration of sustained release L-arginine
|
US20060177504A1
(en)
*
|
2005-02-08 |
2006-08-10 |
Renjit Sundharadas |
Combination pain medication
|
US9149439B2
(en)
*
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
US20060252831A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Christopher Offen |
Method for the treatment of magnesium and potassium deficiencies
|
US20060252830A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Brandon Stephen F |
Method for the treatment of magnesium and potassium deficiencies
|
US20070003490A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Medical Futures Inc. |
Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against NSAID gastropathy
|
US20080021078A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Methods and medicaments for administration of ibuprofen
|
US20070043096A1
(en)
*
|
2005-07-18 |
2007-02-22 |
Horizon Therapeutics, Inc. |
Unit dose form with ibuprofen-famotidine admixture
|
US20080020040A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Unit dose form for administration of ibuprofen
|
US8067451B2
(en)
|
2006-07-18 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Methods and medicaments for administration of ibuprofen
|
EA200800360A1
(ru)
*
|
2005-07-22 |
2008-06-30 |
Мириад Дженетикс, Инк. |
Формуляции с высоким содержанием лекарства и дозированные формы
|
US20080085314A1
(en)
*
|
2005-07-29 |
2008-04-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
US20080166407A1
(en)
*
|
2005-07-29 |
2008-07-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
EP1909769A2
(en)
*
|
2005-08-01 |
2008-04-16 |
Alpharma, Inc. |
Alcohol resistant pharmaceutical formulations
|
AR057181A1
(es)
*
|
2005-11-30 |
2007-11-21 |
Astra Ab |
Nueva forma de dosificacion de combinacion
|
EP1813275A1
(en)
*
|
2005-12-20 |
2007-08-01 |
Teva Pharmaceutical Industries Ltd |
Lansoprazole orally disintegrating tablets
|
WO2007075980A2
(en)
*
|
2005-12-20 |
2007-07-05 |
Teva Pharmaceutical Industries Ltd. |
Lansoprazole orally disintegrating tablets
|
EP1965774A2
(en)
*
|
2005-12-30 |
2008-09-10 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
US8512761B2
(en)
*
|
2006-01-27 |
2013-08-20 |
Yale University |
Fast acting inhibitor of gastric acid secretion
|
DK1976532T3
(da)
*
|
2006-01-27 |
2016-02-01 |
Univ Yale |
Hurtigvirkende inhibitor af mavesyresekretion
|
EP1834634A3
(en)
*
|
2006-03-08 |
2007-10-03 |
Rentschler Pharma GmbH |
Pharmaceutical multiple-unit composition
|
EP1837016A3
(en)
*
|
2006-03-08 |
2008-01-02 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Pharmaceutical multiple-unit composition
|
JP5844028B2
(ja)
|
2006-04-04 |
2016-01-13 |
ケージー アクキュイシチオン エルエルシー |
抗血小板薬及び酸阻害薬を含む経口剤形
|
US9532945B2
(en)
*
|
2006-04-04 |
2017-01-03 |
Kg Acquisition Llc |
Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
|
EP2012756A4
(en)
*
|
2006-04-20 |
2013-01-23 |
Inventia Healthcare Private Ltd |
MULTI-UNIT COMPOSITIONS
|
ES2466441T3
(es)
*
|
2006-04-28 |
2014-06-10 |
Wockhardt Limited |
Composiciones farmacéuticas que comprenden fármaco antiinflamatorio no esteroideo, acetaminofén e inhibidor de la bomba de protones
|
US20080033045A1
(en)
*
|
2006-07-07 |
2008-02-07 |
Myriad Genetics, Incorporated |
Treatment of psychiatric disorders
|
US8067033B2
(en)
*
|
2007-11-30 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Stable compositions of famotidine and ibuprofen
|
WO2008018825A1
(en)
*
|
2006-08-10 |
2008-02-14 |
Astrazeneca Ab |
Oral polyvinyl alcohol capsules comprising proton pump inhibitors
|
EP2063873A2
(en)
*
|
2006-08-31 |
2009-06-03 |
Horizon Therapeutics, Inc. |
Nsaid dose unit formulations with h2-receptor antagonists and methods of use
|
GB2444593B
(en)
*
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
US8394415B2
(en)
|
2006-11-21 |
2013-03-12 |
Mcneil-Ppc, Inc |
Modified release analgesic suspensions
|
ITMI20062290A1
(it)
*
|
2006-11-28 |
2008-05-29 |
Monteres S R L |
Compresse stabili allo stoccaggio a base di derivati del benzimidazolo rivestite con film gastro-resistente
|
US20080311162A1
(en)
*
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
WO2008140459A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
US20080286343A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Dzenana Cengic |
Solid form
|
WO2008140460A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
CA2600147A1
(en)
*
|
2007-06-11 |
2008-12-11 |
Nathan Bryson |
Combination for treatment of diabetes mellitus
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
FR2926724B1
(fr)
*
|
2008-01-25 |
2010-06-18 |
Duo Ge |
Nouvelle forme pharmaceutique orale.
|
CA2713197C
(en)
*
|
2008-01-25 |
2016-10-04 |
Duo-Ge |
Combinations of oral medicaments bonded by a wrapping
|
FR2926723B1
(fr)
*
|
2008-01-25 |
2010-06-18 |
Duo Ge |
Associations pharmaceutiques orales.
|
US20090252791A1
(en)
*
|
2008-04-02 |
2009-10-08 |
Venkata Nookaraju Sreedharala |
Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
|
WO2009152551A1
(en)
*
|
2008-06-20 |
2009-12-23 |
Alphapharm Pty Ltd |
Pharmaceutical formulation
|
WO2010018593A2
(en)
*
|
2008-07-03 |
2010-02-18 |
Torrent Pharmaceuticals Ltd. |
Gastric acid resistant benzimidazole multiple unit tablet composition
|
US8807070B2
(en)
*
|
2008-08-07 |
2014-08-19 |
Vector Corporation |
Rotor processor for dry powders
|
US20100034968A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Vector Corporation |
Polymer coating process using dry glidant in a rotor processor
|
US20100034967A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Vector Corporation |
Dry polymer layering using a rotor processor
|
US20110144207A1
(en)
*
|
2008-08-14 |
2011-06-16 |
Shasun Chemicals And Drugs Limited |
Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
|
JP2012502015A
(ja)
|
2008-09-09 |
2012-01-26 |
アストラゼネカ・アクチエボラーグ |
必要がある患者に医薬組成物を送達するための方法
|
CA2750196C
(en)
*
|
2009-01-05 |
2017-06-20 |
Mcneil-Ppc, Inc. |
Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
|
US8377475B2
(en)
*
|
2009-01-05 |
2013-02-19 |
Mcneil-Ppc, Inc. |
Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
|
CA2748783A1
(en)
*
|
2009-01-05 |
2010-07-08 |
Mcneil-Ppc, Inc. |
Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
|
AU2010239081C1
(en)
|
2009-04-24 |
2014-11-06 |
Iceutica Pty Ltd |
A novel formulation of indomethacin
|
KR20120029398A
(ko)
|
2009-04-24 |
2012-03-26 |
아이슈티카 피티와이 리미티드 |
디클로페낙의 신규 제형
|
US20100305163A1
(en)
*
|
2009-05-20 |
2010-12-02 |
Pramod Dattatray Yedurkar |
Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
|
MX2011013467A
(es)
|
2009-06-25 |
2012-02-13 |
Astrazeneca Ab |
Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
|
NZ597534A
(en)
*
|
2009-06-25 |
2013-09-27 |
Pozen Inc |
Method for treating a patient in need of aspirin therapy
|
BRPI1016013A2
(pt)
*
|
2009-06-29 |
2016-04-26 |
Mcneil Ppc Inc |
tablete farmacêutico contendo uma cápsula preenchida com líquido.
|
RU2010108361A
(ru)
*
|
2010-03-09 |
2011-09-20 |
Гаврилова Эмилия Евгеньевна (RU) |
Набор лечебных средств
|
WO2011144994A1
(en)
*
|
2010-05-21 |
2011-11-24 |
Lupin Limited |
Pharmaceutical compositions of nsaid and acid inhibitor
|
EP2601936A4
(en)
*
|
2010-08-03 |
2014-03-19 |
Eisai R&D Man Co Ltd |
COMPRESSED COMPOSITION
|
DE102010052847A1
(de)
|
2010-11-29 |
2012-05-31 |
Temmler Werke Gmbh |
Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
|
PE20140005A1
(es)
*
|
2010-12-03 |
2014-01-23 |
Takeda Pharmaceutical |
Tableta oralmente desintegradora
|
RU2600440C3
(ru)
|
2010-12-16 |
2021-12-10 |
Ново Нордиск А/С |
Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты
|
KR20180027641A
(ko)
*
|
2011-02-02 |
2018-03-14 |
알파마 파머슈티컬스 엘엘씨 |
오피오이드 효능제 및 격리된 길항제를 포함하는 제약 조성물
|
WO2012140117A1
(en)
|
2011-04-12 |
2012-10-18 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
TR201103752A2
(tr)
|
2011-04-18 |
2012-11-21 |
Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. |
Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.
|
US10463611B2
(en)
*
|
2011-06-08 |
2019-11-05 |
Sti Pharma, Llc |
Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration
|
CN102406938A
(zh)
*
|
2011-11-29 |
2012-04-11 |
北京阜康仁生物制药科技有限公司 |
一种抗血栓的药物组合物
|
CA2857457C
(en)
*
|
2011-11-30 |
2018-05-01 |
Takeda Pharmaceutical Company Limited |
Dry coated tablet
|
MX2014007935A
(es)
|
2011-12-28 |
2014-11-14 |
Pozen Inc |
Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
|
MX354454B
(es)
|
2012-03-20 |
2018-03-06 |
Laboratorios Bago S A |
Procedimiento de elaboracion de microcapsulas entericas de alginato por gelacion ionica que contienen diclofenac o una de sus sales y composicion farmaceutica multiparticulada que las contiene.
|
RS64942B1
(sr)
|
2012-03-22 |
2024-01-31 |
Novo Nordisk As |
Kompozicije koje obuhvataju sredstvo za isporuku i njihova priprema
|
DK2827845T3
(da)
|
2012-03-22 |
2019-04-01 |
Novo Nordisk As |
Sammensætninger omfattende et fremføringsmiddel og fremstilling deraf
|
ES2952874T3
(es)
|
2012-03-22 |
2023-11-06 |
Novo Nordisk As |
Composiciones de péptidos GLP-1 y preparación de estas
|
KR101907690B1
(ko)
*
|
2012-04-12 |
2018-10-15 |
한미약품 주식회사 |
비스테로이드성 항염증약물 및 프로톤 펌프 저해제를 포함하는 약제학적 복합제제 및 이의 제조방법
|
KR101378973B1
(ko)
*
|
2012-04-13 |
2014-03-28 |
한미약품 주식회사 |
구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
|
CN104487056A
(zh)
|
2012-06-20 |
2015-04-01 |
诺和诺德A/S(股份有限公司) |
包含肽和递送剂的片剂制剂
|
WO2014189034A1
(ja)
*
|
2013-05-21 |
2014-11-27 |
武田薬品工業株式会社 |
口腔内崩壊錠
|
WO2015150943A1
(en)
|
2014-03-29 |
2015-10-08 |
Wockhardt Limited |
Pharmaceutical composition of nsaid and ppi or salt thereof
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
KR101723266B1
(ko)
*
|
2014-08-13 |
2017-04-05 |
영남대학교 산학협력단 |
비스테로이드성 항염증약물 및 프로톤 펌프 저해제를 포함하는 경구용 속방형 조성물 및 그 제조방법
|
CN104208039B
(zh)
*
|
2014-08-26 |
2017-05-03 |
杭州新诺华医药有限公司 |
一种萘普生埃索美拉唑镁肠溶制剂及制备方法
|
EP3236952B1
(en)
*
|
2014-12-23 |
2019-07-03 |
KRKA, d.d., Novo mesto |
Pharmaceutical tablet composition
|
EP3288556A4
(en)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
JP6778680B2
(ja)
|
2015-07-30 |
2020-11-04 |
武田薬品工業株式会社 |
錠剤
|
CN106668017A
(zh)
*
|
2015-11-11 |
2017-05-17 |
上海星泰医药科技有限公司 |
萘普生和埃索美拉唑镁复方肠溶胶囊及其制备方法
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
TR201618765A2
(tr)
|
2016-12-16 |
2018-07-23 |
Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi |
Ağrı ve enflamasyonun tedavisi için steroid olmayan anti-enflamatuvar ilaçlar ve H2 reseptörü antagonisti kombinasyonları.
|
TR201718099A2
(tr)
|
2017-11-16 |
2019-06-21 |
Mehmet Nevzat Pisak |
Ağri ve enflamasyonun tedavi̇si̇ i̇çi̇n di̇klofenak, h2 reseptör antagoni̇stleri̇ ve alkali̇ metal bi̇karbonatlarindan olusan kombi̇nasyonlar
|
WO2019135725A1
(en)
|
2018-01-03 |
2019-07-11 |
Pisak Mehmet Nevzat |
Combinations of selective cox-2 inhibitor nsaids and h2 receptor antagonists for fast treatment of pain and inflammation
|
MA53076B1
(fr)
|
2018-02-02 |
2023-11-30 |
Novo Nordisk As |
Compositions solides comportant un agoniste glp-1, du sel d'acide n-(8-(2-hydroxybenzoyl)amino)caprylate et un lubrifiant
|
WO2019240310A1
(ko)
*
|
2018-06-14 |
2019-12-19 |
한국유나이티드제약 주식회사 |
아세클로페낙과 에스오메프라졸을 포함하는 복합제제 및 그 제조방법
|
RU2732297C2
(ru)
*
|
2018-11-14 |
2020-09-15 |
Общество с ограниченной ответственностью "Гурус БиоФарм" |
Производные нестероидных противовоспалительных средств
|
EP4070789A4
(en)
*
|
2020-01-23 |
2024-01-24 |
Hanmi Pharm Ind Co Ltd |
PHARMACEUTICAL COMPOSITE FORMULATION WITH PROTON PUMP INHIBITOR AND ANTACID
|
AU2021256161A1
(en)
*
|
2020-04-13 |
2022-12-15 |
Hk Inno.N Corporation |
Pharmaceutical composition comprising benzimidazole derivative compound
|
KR20230031287A
(ko)
*
|
2021-08-26 |
2023-03-07 |
컨템포러리 엠퍼렉스 테크놀로지 씨오., 리미티드 |
액체 백, 전지 셀, 전지 및 전기 장치
|
WO2023129069A2
(en)
*
|
2021-12-29 |
2023-07-06 |
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi |
A pharmaceutical composition comprising naproxen and esomeprazole
|
KR102553713B1
(ko)
*
|
2022-11-18 |
2023-07-10 |
고덕상 |
미네랄 촉매제를 이용한 양식어류사료 제조방법
|